SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Advanced Viral Research CP (ADVR)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: OLD JAKE JUSTUS who wrote (2236)5/20/1997 5:09:00 PM
From: Tom Jones   of 2281
 
No longer do I lurk, I've procrastinated this ambush for far too long. The reason is due
in large part to the fact that I have been too lazy to send in a postcard to SI so they
would allow me to post. Well now permission to me has been granted by them.
Greetings to all.

I, like many of you, have been an ADVR shareholder for a very long time. My patience
and wallet grew thin long ago. Many of you have raised issues concerning things about which I, quite frankly, could not care less. I'm in it for the
money. And here I stay, a believer in what rests in Reticulose.

I chose to reply to for two reasons:

1. To provide humble, but critical, feedback on all ADVR communications efforts;
2. To suggest how we may be able to tell the ADVR story to a broader financial
audience and, therefore, create awareness and demand for ADVR stock.

First of all, I write news releases for a living. It may be hard to believe, but its true that
guys like me make money developing promulgated propaganda that you see on the
news wires every morning. Nothing, nothing, nothing, nothing frustrates me more than
when I see a company (especially one with whom I own stock) distribute news
releases that are written by lawyers. Our company has a story to tell and they should
and could tell it a hell of a lot more creatively, and with more compelling emphasis than
they have been.

For starters, these news releases must be written with greater newsworthiness. The
headline on each ADVR news release has not changed in two years. Let me explain
why this in particular hurts us.

I feel that we must poke holes in the format and distribution methods of all ADVR news releases because unless we change, we're just casting deep-sea fishing hooks into mud puddles. Advanced Viral has a chance to play the dark horse taking the turf. Some sound communications strategies can make that happen.

Lastly, I realize that public relations is not a priority for ADVR, but I'm not pleased with the existing investor relations that is in place now. It seems that we're paying guys to take calls from shareholders just to banter about our stock when they should be aggressively contacting reporters and journalists at the financial
media outlets to arrange interviews with key ADVR players. This has to happen.

In addition, ADVR releases should be sent in embargoed format to Dow Jones Reuters, Bloomberg, Associated Press, Investor's Business Daily and The Wall Street Journal.

Just some thoughts. Hope they're useful.

Tom Jones
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext